 | • レポートコード：D0GIR-02288 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ナルコレプシー治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。ナルコレプシー治療薬の種類別市場規模（オキシ酸ナトリウム、抗うつ剤、中枢神経刺激剤、その他）、用途別市場規模（カタプレキシー原発性ナルコレプシー、カタプレキシーなし原発性ナルコレプシー、病状によるナルコレプシー、不特定ナルコレプシー）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Teva Pharmaceutical、Arena Pharmaceuticals、Takeda、Jazz Pharmaceuticals、Ligand Pharmaceuticals、Graymark Healthcare ・地域別グローバル市場分析 2015年-2020年 ・ナルコレプシー治療薬の北米市場（アメリカ、カナダ、メキシコ） ・ナルコレプシー治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ナルコレプシー治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ナルコレプシー治療薬の南米市場（ブラジル、アルゼンチン） ・ナルコレプシー治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：オキシ酸ナトリウム、抗うつ剤、中枢神経刺激剤、その他 ・用途別分析：カタプレキシー原発性ナルコレプシー、カタプレキシーなし原発性ナルコレプシー、病状によるナルコレプシー、不特定ナルコレプシー ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Narcolepsy Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Narcolepsy Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Narcolepsy Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Narcolepsy Treatment market has been segmented into:
Sodium Oxybate
Antidepressants
Central Nervous System Stimulants
Others
By Application, Narcolepsy Treatment has been segmented into:
Primary Narcolepsy with Cataplexy
Primary Narcolepsy without Cataplexy
Narcolepsy Due to Medical Conditions
Unspecified Narcolepsy
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Narcolepsy Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Narcolepsy Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Narcolepsy Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Narcolepsy Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Narcolepsy Treatment Market Share Analysis
Narcolepsy Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Narcolepsy Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Narcolepsy Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Narcolepsy Treatment are:
Teva Pharmaceutical
Arena Pharmaceuticals
Takeda
Jazz Pharmaceuticals
Ligand Pharmaceuticals
Graymark Healthcare
Table of Contents
1 Narcolepsy Treatment Market Overview
1.1 Product Overview and Scope of Narcolepsy Treatment
1.2 Classification of Narcolepsy Treatment by Type
1.2.1 Global Narcolepsy Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Narcolepsy Treatment Revenue Market Share by Type in 2019
1.2.3 Sodium Oxybate
1.2.4 Antidepressants
1.2.5 Central Nervous System Stimulants
1.2.6 Others
1.3 Global Narcolepsy Treatment Market by Application
1.3.1 Overview: Global Narcolepsy Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Primary Narcolepsy with Cataplexy
1.3.3 Primary Narcolepsy without Cataplexy
1.3.4 Narcolepsy Due to Medical Conditions
1.3.5 Unspecified Narcolepsy
1.4 Global Narcolepsy Treatment Market by Regions
1.4.1 Global Narcolepsy Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Narcolepsy Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Narcolepsy Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Narcolepsy Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Narcolepsy Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Narcolepsy Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Narcolepsy Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Teva Pharmaceutical
2.1.1 Teva Pharmaceutical Details
2.1.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Teva Pharmaceutical SWOT Analysis
2.1.4 Teva Pharmaceutical Product and Services
2.1.5 Teva Pharmaceutical Narcolepsy Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Arena Pharmaceuticals
2.2.1 Arena Pharmaceuticals Details
2.2.2 Arena Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Arena Pharmaceuticals SWOT Analysis
2.2.4 Arena Pharmaceuticals Product and Services
2.2.5 Arena Pharmaceuticals Narcolepsy Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Takeda SWOT Analysis
2.3.4 Takeda Product and Services
2.3.5 Takeda Narcolepsy Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Jazz Pharmaceuticals
2.4.1 Jazz Pharmaceuticals Details
2.4.2 Jazz Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Jazz Pharmaceuticals SWOT Analysis
2.4.4 Jazz Pharmaceuticals Product and Services
2.4.5 Jazz Pharmaceuticals Narcolepsy Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ligand Pharmaceuticals
2.5.1 Ligand Pharmaceuticals Details
2.5.2 Ligand Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Ligand Pharmaceuticals SWOT Analysis
2.5.4 Ligand Pharmaceuticals Product and Services
2.5.5 Ligand Pharmaceuticals Narcolepsy Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Graymark Healthcare
2.6.1 Graymark Healthcare Details
2.6.2 Graymark Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Graymark Healthcare SWOT Analysis
2.6.4 Graymark Healthcare Product and Services
2.6.5 Graymark Healthcare Narcolepsy Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Narcolepsy Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Narcolepsy Treatment Players Market Share
3.2.2 Top 10 Narcolepsy Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Narcolepsy Treatment Revenue and Market Share by Regions
4.2 North America Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
5 North America Narcolepsy Treatment Revenue by Countries
5.1 North America Narcolepsy Treatment Revenue by Countries (2015-2020)
5.2 USA Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
6 Europe Narcolepsy Treatment Revenue by Countries
6.1 Europe Narcolepsy Treatment Revenue by Countries (2015-2020)
6.2 Germany Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
6.4 France Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Narcolepsy Treatment Revenue by Countries
7.1 Asia-Pacific Narcolepsy Treatment Revenue by Countries (2015-2020)
7.2 China Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
7.5 India Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
8 South America Narcolepsy Treatment Revenue by Countries
8.1 South America Narcolepsy Treatment Revenue by Countries (2015-2020)
8.2 Brazil Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Narcolepsy Treatment by Countries
9.1 Middle East & Africa Narcolepsy Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Narcolepsy Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Narcolepsy Treatment Market Forecast by Type (2019-2024)
10.3 Sodium Oxybate Revenue Growth Rate (2015-2025)
10.4 Antidepressants Revenue Growth Rate (2015-2025)
10.5 Central Nervous System Stimulants Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Narcolepsy Treatment Market Segment by Application
11.1 Global Narcolepsy Treatment Revenue Market Share by Application (2015-2020)
11.2 Narcolepsy Treatment Market Forecast by Application (2019-2024)
11.3 Primary Narcolepsy with Cataplexy Revenue Growth (2015-2020)
11.4 Primary Narcolepsy without Cataplexy Revenue Growth (2015-2020)
11.5 Narcolepsy Due to Medical Conditions Revenue Growth (2015-2020)
11.6 Unspecified Narcolepsy Revenue Growth (2015-2020)
12 Global Narcolepsy Treatment Market Size Forecast (2021-2025)
12.1 Global Narcolepsy Treatment Market Size Forecast (2021-2025)
12.2 Global Narcolepsy Treatment Market Forecast by Regions (2021-2025)
12.3 North America Narcolepsy Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Narcolepsy Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Narcolepsy Treatment Revenue Market Forecast (2021-2025)
12.6 South America Narcolepsy Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Narcolepsy Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Narcolepsy Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Narcolepsy Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Narcolepsy Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Narcolepsy Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Teva Pharmaceutical Corporate Information, Location and Competitors
Table 6. Teva Pharmaceutical Narcolepsy Treatment Major Business
Table 7. Teva Pharmaceutical Narcolepsy Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Teva Pharmaceutical SWOT Analysis
Table 9. Teva Pharmaceutical Narcolepsy Treatment Product and Solutions
Table 10. Teva Pharmaceutical Narcolepsy Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Arena Pharmaceuticals Corporate Information, Location and Competitors
Table 12. Arena Pharmaceuticals Narcolepsy Treatment Major Business
Table 13. Arena Pharmaceuticals Narcolepsy Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Arena Pharmaceuticals SWOT Analysis
Table 15. Arena Pharmaceuticals Narcolepsy Treatment Product and Solutions
Table 16. Arena Pharmaceuticals Narcolepsy Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Takeda Corporate Information, Location and Competitors
Table 18. Takeda Narcolepsy Treatment Major Business
Table 19. Takeda Narcolepsy Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Takeda SWOT Analysis
Table 21. Takeda Narcolepsy Treatment Product and Solutions
Table 22. Takeda Narcolepsy Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Jazz Pharmaceuticals Corporate Information, Location and Competitors
Table 24. Jazz Pharmaceuticals Narcolepsy Treatment Major Business
Table 25. Jazz Pharmaceuticals Narcolepsy Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Jazz Pharmaceuticals SWOT Analysis
Table 27. Jazz Pharmaceuticals Narcolepsy Treatment Product and Solutions
Table 28. Jazz Pharmaceuticals Narcolepsy Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Ligand Pharmaceuticals Corporate Information, Location and Competitors
Table 30. Ligand Pharmaceuticals Narcolepsy Treatment Major Business
Table 31. Ligand Pharmaceuticals Narcolepsy Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Ligand Pharmaceuticals SWOT Analysis
Table 33. Ligand Pharmaceuticals Narcolepsy Treatment Product and Solutions
Table 34. Ligand Pharmaceuticals Narcolepsy Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Graymark Healthcare Corporate Information, Location and Competitors
Table 36. Graymark Healthcare Narcolepsy Treatment Major Business
Table 37. Graymark Healthcare Narcolepsy Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Graymark Healthcare SWOT Analysis
Table 39. Graymark Healthcare Narcolepsy Treatment Product and Solutions
Table 40. Graymark Healthcare Narcolepsy Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Narcolepsy Treatment Revenue (Million USD) by Players (2015-2020)
Table 42. Global Narcolepsy Treatment Revenue Share by Players (2015-2020)
Table 43. Global Narcolepsy Treatment Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Narcolepsy Treatment Revenue Market Share by Regions (2015-2020)
Table 45. North America Narcolepsy Treatment Revenue by Countries (2015-2020)
Table 46. North America Narcolepsy Treatment Revenue Market Share by Countries (2015-2020)
Table 47. Europe Narcolepsy Treatment Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Narcolepsy Treatment Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Narcolepsy Treatment Revenue by Countries (2015-2020)
Table 50. South America Narcolepsy Treatment Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Narcolepsy Treatment Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Narcolepsy Treatment Revenue Market Share by Countries (2015-2020)
Table 53. Global Narcolepsy Treatment Revenue (Million USD) by Type (2015-2020)
Table 54. Global Narcolepsy Treatment Revenue Share by Type (2015-2020)
Table 55. Global Narcolepsy Treatment Revenue Forecast by Type (2021-2025)
Table 56. Global Narcolepsy Treatment Revenue by Application (2015-2020)
Table 57. Global Narcolepsy Treatment Revenue Share by Application (2015-2020)
Table 58. Global Narcolepsy Treatment Revenue Forecast by Application (2021-2025)
Table 59. Global Narcolepsy Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Narcolepsy Treatment Picture
Figure 2. Global Narcolepsy Treatment Revenue Market Share by Type in 2019
Figure 3. Sodium Oxybate Picture
Figure 4. Antidepressants Picture
Figure 5. Central Nervous System Stimulants Picture
Figure 6. Others Picture
Figure 7. Narcolepsy Treatment Revenue Market Share by Application in 2019
Figure 8. Primary Narcolepsy with Cataplexy Picture
Figure 9. Primary Narcolepsy without Cataplexy Picture
Figure 10. Narcolepsy Due to Medical Conditions Picture
Figure 11. Unspecified Narcolepsy Picture
Figure 12. Global Narcolepsy Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Narcolepsy Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Narcolepsy Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Narcolepsy Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Narcolepsy Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Narcolepsy Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Narcolepsy Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Narcolepsy Treatment Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Narcolepsy Treatment Revenue Market Share in 2019
Figure 21. Global Top 10 Players Narcolepsy Treatment Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Narcolepsy Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Narcolepsy Treatment Revenue Market Share by Regions (2015-2020)
Figure 25. Global Narcolepsy Treatment Revenue Market Share by Regions in 2018
Figure 26. North America Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Europe Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 29. South America Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 31. North America Narcolepsy Treatment Revenue Market Share by Countries (2015-2020)
Figure 32. North America Narcolepsy Treatment Revenue Market Share by Countries in 2019
Figure 33. USA Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Canada Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Europe Narcolepsy Treatment Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Narcolepsy Treatment Revenue Market Share by Countries in 2019
Figure 38. Germany Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 39. UK Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 40. France Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Russia Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Italy Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Narcolepsy Treatment Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Narcolepsy Treatment Revenue Market Share by Countries in 2019
Figure 45. China Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Japan Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Korea Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 48. India Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 50. South America Narcolepsy Treatment Revenue Market Share by Countries (2015-2020)
Figure 51. South America Narcolepsy Treatment Revenue Market Share by Countries in 2019
Figure 52. Brazil Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Narcolepsy Treatment Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Narcolepsy Treatment Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 57. UAE Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Narcolepsy Treatment Revenue and Growth Rate (2015-2020)
Figure 60. Global Narcolepsy Treatment Revenue Share by Type (2015-2020)
Figure 61. Global Narcolepsy Treatment Revenue Share by Type in 2019
Figure 62. Global Narcolepsy Treatment Market Share Forecast by Type (2021-2025)
Figure 63. Global Sodium Oxybate Revenue Growth Rate (2015-2020)
Figure 64. Global Antidepressants Revenue Growth Rate (2015-2020)
Figure 65. Global Central Nervous System Stimulants Revenue Growth Rate (2015-2020)
Figure 66. Global Others Revenue Growth Rate (2015-2020)
Figure 67. Global Narcolepsy Treatment Revenue Share by Application (2015-2020)
Figure 68. Global Narcolepsy Treatment Revenue Share by Application in 2019
Figure 69. Global Narcolepsy Treatment Market Share Forecast by Application (2021-2025)
Figure 70. Global Primary Narcolepsy with Cataplexy Revenue Growth Rate (2015-2020)
Figure 71. Global Primary Narcolepsy without Cataplexy Revenue Growth Rate (2015-2020)
Figure 72. Global Narcolepsy Due to Medical Conditions Revenue Growth Rate (2015-2020)
Figure 73. Global Unspecified Narcolepsy Revenue Growth Rate (2015-2020)
Figure 74. Global Narcolepsy Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Narcolepsy Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Narcolepsy Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Narcolepsy Treatment Revenue Market Forecast (2021-2025)
Figure 78. Europe Narcolepsy Treatment Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Narcolepsy Treatment Revenue Market Forecast (2021-2025)
Figure 80. South America Narcolepsy Treatment Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Narcolepsy Treatment Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
中枢神経系（CNS）リンパ腫治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Central Nervous System (CNS) Lymphoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players,…- 交流電場腫瘍治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Alternating Electric Field Tumor Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Al…
- EDI水処理システムの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The EDI Water Treatment System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 電気脱イオンEDI水処理システムの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Electrodeionization EDI Water Treatment System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, …
- 産業用EDI水処理システムの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Industrial EDI Water Treatment System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…